Free Trial

Aflac Incorporated (NYSE:AFL) Stock Position Increased by Mather Group LLC.

Aflac logo with Finance background

Mather Group LLC. boosted its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 1.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 141,406 shares of the financial services provider's stock after purchasing an additional 2,388 shares during the period. Mather Group LLC.'s holdings in Aflac were worth $15,723,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in AFL. Golden State Wealth Management LLC grew its stake in shares of Aflac by 121.9% during the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock valued at $34,000 after acquiring an additional 167 shares in the last quarter. Curio Wealth LLC acquired a new stake in shares of Aflac during the fourth quarter worth approximately $36,000. Garde Capital Inc. bought a new stake in shares of Aflac in the first quarter worth $36,000. OFI Invest Asset Management acquired a new stake in Aflac in the fourth quarter valued at $38,000. Finally, Capital A Wealth Management LLC acquired a new stake in Aflac in the fourth quarter valued at $38,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the transaction, the director owned 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the sale, the director owned 6,728 shares in the company, valued at approximately $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,750 shares of company stock valued at $4,304,295 in the last quarter. Corporate insiders own 0.90% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on AFL shares. Morgan Stanley upped their target price on shares of Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Wall Street Zen downgraded Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. JPMorgan Chase & Co. lifted their target price on Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Raymond James Financial dropped their price target on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research report on Thursday, May 29th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a report on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $106.50.

Read Our Latest Analysis on AFL

Aflac Stock Performance

Shares of AFL stock traded down $2.27 during trading hours on Wednesday, reaching $103.51. The stock had a trading volume of 1,968,327 shares, compared to its average volume of 2,151,680. The firm has a market capitalization of $55.96 billion, a PE ratio of 16.17, a price-to-earnings-growth ratio of 3.27 and a beta of 0.81. The firm has a 50-day simple moving average of $104.51 and a 200-day simple moving average of $105.22. Aflac Incorporated has a twelve month low of $88.00 and a twelve month high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. Aflac's revenue for the quarter was down 37.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.66 EPS. As a group, equities analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were given a $0.58 dividend. This represents a $2.32 annualized dividend and a yield of 2.24%. The ex-dividend date was Wednesday, May 21st. Aflac's dividend payout ratio is currently 36.25%.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Should You Invest $1,000 in Aflac Right Now?

Before you consider Aflac, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.

While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines